Herschorn, S., Kohan, A., Aliotta, P., McCammon, K., Rajagopalan, S., Everaert, K.. The Efficacy and Safety of Onabotulinumtoxin A or Solifenacin Compared with Placebo in Solifenacin-Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind, Phase 3b Trial. Journal of Urology. 2017.
Dmochowski, R, Aliotta, P, Blok, B, Castro-Diaz, D, Denys, P, Ethans, K, Joshi, M, Magyar, A, Kennelly, M.. Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity.. BJU. 2017.
"Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." International Neurotoxin Association Meeting (TOXINS) (2017)
"The Efficacy and Safety of Onabotulinumtoxin A and Solifenacin Compared to Placebo in Solifenacin-Naïve Patients with Idiopathic Overactive Bladder: Results from a Multicentre, Randomised, Double-Blind Trial" British Association of Urological (2016)
"Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." Society of Urodynamics, Female Pelvic Medicine & Urogentical Reconstruction (2016)
"Long Term Sustained Safety and Efficacy if Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." Italian Society of Urodynamics, (2015)
"Perirectal Hydrogel Spacer Application in Men Receiving Prostate Radiotherapy: A Prospective Multicenter Randomized Controlled Trial." American Urological Association (2015)
"Positive Response to First Onabotulinumtoxin A Treatment Persists Long-term with Repeat Treatments in Patients with Neurogenic Detrusor Overactivity" Congress of the European association of Urology (2015)
". Long Term, Sustained Safety and Efficacy of Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." American Committee for Treatment and Research in MS/European Committee for Treatment and Research (2014)
Service Activities:
Chief of Urology (2018–present)
Sisters Hospital Representative of the Catholic Health Medical Executive Committee (2016–present)
Department of Urology; Chair (2009–present)
Consortium for Multiple Sclerosis Centers Chair Bladder/Pelvic Floor; Chair (2008–present)
Catholic Health System of WNY; Board Member (2007–present)
Niagara Health Care Quality Council (2005–present)
Office Professional Medical Conduct, Department of Health New York State Urologic Reviewer; Reporter (2002–present)
School News:
In the Media:
Clinical Specialties:
Clinical Offices:
Insurance Accepted:
Contact Information
Western New York Urology Associates 3085 Harlem Road, Suite 200 Cheektowaga, NY 14225 Phone: 716-844-5000 aliotta@buffalo.edu
